TAGRISSO
Drug timelines are a Plus or Pro feature.
106 regulatory and trial events tracked for TAGRISSO, covering 2015-07-30 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Tagrisso (osimertinib mesilate) — AstraZeneca AB
106 regulatory and trial events tracked for TAGRISSO, covering 2015-07-30 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Tagrisso (osimertinib mesilate) — AstraZeneca AB